Ten predictors with the greatest influence on DFS in CRC patients were determined (Supplementary Table S5), of which 8 were risk genes (TIAL1, C1orf198, CLK1, PTPRN, LSMEM1, ANKRD13D, ATP6AP1, and SKAP1), and 2 were protective genes (ERAP1 and ANKRD17) (Figures 3D–F). This evidence concerns the gene ANKRD17 and colorectal carcinoma.